Van ECK Associates Corp Purchases 30,535 Shares of Ventas, Inc. $VTR

Van ECK Associates Corp raised its holdings in shares of Ventas, Inc. (NYSE:VTR) by 10.2% during the 2nd quarter, Holdings Channel.com reports. The firm owned 331,350 shares of the real estate investment trust’s stock after acquiring an additional 30,535 shares during the quarter. Van ECK Associates Corp’s holdings in Ventas were worth $29,424,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in VTR. Dynamic Wealth Strategies LLC bought a new stake in shares of Ventas in the first quarter valued at approximately $25,000. Wiser Advisor Group LLC bought a new position in Ventas in the 3rd quarter worth approximately $27,000. Silvant Capital Management LLC bought a new position in Ventas in the 2nd quarter worth approximately $28,000. Meeder Asset Management Inc. purchased a new position in Ventas in the 2nd quarter valued at approximately $30,000. Finally, IFC & Insurance Marketing Inc. purchased a new position in Ventas in the 4th quarter valued at approximately $30,000. Institutional investors own 94.18% of the company’s stock.

Ventas Stock Down 0.0%

VTR opened at $91.78 on Monday. The company has a fifty day moving average price of $92.42 and a 200-day moving average price of $87.61. The firm has a market capitalization of $47.08 billion, a P/E ratio of 169.96, a price-to-earnings-growth ratio of 2.11 and a beta of 0.69. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.44 and a quick ratio of 0.44. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60.

Ventas (NYSE:VTR) last released its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The firm had revenue of $1.73 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same quarter in the prior year, the firm posted $0.87 earnings per share. The business’s quarterly revenue was up 21.7% on a year-over-year basis. Equities research analysts expect that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The shares were purchased at an average price of $78.81 per share, with a total value of $197,025.00. Following the acquisition, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.53% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Cantor Fitzgerald increased their target price on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Weiss Ratings upgraded Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, July 21st. Barclays initiated coverage on Ventas in a report on Tuesday, July 7th. They set an “equal weight” rating and a $99.00 price objective on the stock. Wells Fargo & Company lifted their target price on Ventas from $93.00 to $96.00 and gave the company an “overweight” rating in a report on Monday, June 1st. Finally, Royal Bank Of Canada upped their price target on Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research report on Friday, August 14th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, Ventas currently has an average rating of “Moderate Buy” and an average target price of $98.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.